APA (7th ed.) Citation

N, H., RHJ, M., A, C., HJ, G., & JE, K. (2025). Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels. European journal of cancer (Oxford, England : 1990), 230, 115806. https://doi.org/10.1016/j.ejca.2025.115806

Chicago Style (17th ed.) Citation

N, Heersche, Mathijssen RHJ, Cats A, Guchelaar HJ, and Knikman JE. "Response to Letter Re: Dose-individualisation of Fluoropyrimidines Based on Pre-treatment Serum Uracil Levels." European Journal of Cancer (Oxford, England : 1990) 230 (2025): 115806. https://doi.org/10.1016/j.ejca.2025.115806.

MLA (9th ed.) Citation

N, Heersche, et al. "Response to Letter Re: Dose-individualisation of Fluoropyrimidines Based on Pre-treatment Serum Uracil Levels." European Journal of Cancer (Oxford, England : 1990), vol. 230, 2025, p. 115806, https://doi.org/10.1016/j.ejca.2025.115806.